Testosterone treatment increases plasma cholesteryl ester transfer protein (CETP) and decreases hepatic lipase activities in genetic modified mice

被引:0
|
作者
Casquero, AC [1 ]
Teixeira, LLS [1 ]
Patricio, PR [1 ]
Dorighello, GG [1 ]
Salerno, AG [1 ]
Bighetti, EJB [1 ]
Oliveira, HCF [1 ]
机构
[1] UNICAMP, Campinas, SP, Brazil
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:74 / 74
页数:1
相关论文
共 50 条
  • [21] Inhibition of cholesteryl ester transfer protein (CETP) activity increases paraoxonase (Pon1) activity toward paraoxon and decreases plasma lysophosphatidylcholine (LysoPC) levels
    Zhang, B
    Fan, P
    Shimoji, E
    Saku, K
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 70 - 70
  • [22] Remodeling of high density lipoproteins (HDL) by cholesteryl ester transfer protein (CETP) and hepatic lipase enhance uptake of HDL cholesteryl ester by cellular scavenger receptor B-I.
    Collet, X
    Francone, OL
    Serajuddin, H
    Guendouzi, K
    Royer, L
    Jiang, XC
    Barbaras, R
    Oliveira, H
    CIRCULATION, 1998, 98 (17) : 34 - 34
  • [23] DIFFERENT LOCATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN AND PHOSPHOLIPID TRANSFER PROTEIN ACTIVITIES IN PLASMA
    SPEIJER, H
    GROENER, JEM
    VANRAMSHORST, E
    VANTOL, A
    ATHEROSCLEROSIS, 1991, 90 (2-3) : 159 - 168
  • [24] CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects
    Thomas, Tiffany
    Zhou, Haihong
    Karmally, Wahida
    Ramakrishnan, Rajasekhar
    Holleran, Stephen
    Liu, Yang
    Jumes, Patricia
    Wagner, John A.
    Hubbard, Brian
    Previs, Stephen F.
    Roddy, Thomas
    Johnson-Levonas, Amy O.
    Gutstein, David E.
    Marcovina, Santica M.
    Rader, Daniel J.
    Ginsberg, Henry N.
    Millar, John S.
    Reyes-Soffer, Gissette
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (09) : 1770 - +
  • [25] Torcetrapib inhibits cholesteryl ester transfer protein and increases HDL in CETP.APOE*3-Leiden transgenic mice
    De Haan, W.
    Van der Hoogt, C. C.
    Van den Hoogen, C. M.
    Dallinga-Thie, G. M.
    Princen, H. M. G.
    Jukema, J. W.
    Havekes, L. M.
    Rensen, P. C. N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 551 - 551
  • [26] Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice
    Gautier, T
    Masson, D
    Jong, MC
    De Barros, JPP
    Duverneuil, L
    Le Guern, N
    Deckert, V
    Dumont, L
    Bataille, A
    Zak, Z
    Jiang, XC
    Havekes, LM
    Lagrost, L
    BIOCHEMICAL JOURNAL, 2005, 385 : 189 - 195
  • [27] Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: Effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis
    Soyal, Selma M.
    Sandhofer, Anton
    Hahne, Penelope
    Oberkofler, Hannes
    Felder, Thomas
    Iglseder, Bernhard
    Miller, Karl
    Krempler, Franz
    Patsch, Josef R.
    Paulweber, Bernhard
    Patsch, Wolfgang
    ATHEROSCLEROSIS, 2011, 216 (02) : 374 - 380
  • [28] Application of Genetic Epidemiology to CETP (Cholesteryl Ester Transfer Protein) Concentration and Risk of Cardiovascular Disease
    Merriman, Tony R.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (05):
  • [29] EFFECTS OF DIETARY-CHOLESTEROL ON PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) CONCENTRATION IN MAN
    MCPHERSON, R
    MARTIN, L
    ZHANG, ZJ
    CONNELLY, PW
    MARCEL, YL
    ARTERIOSCLEROSIS, 1990, 10 (05): : A818 - A818
  • [30] A FAMILY WITH COMPLETE DEFICIENCY OF PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITIES
    MAKITA, H
    TSUJI, M
    FURYA, Y
    TSUCHIHASHI, K
    AKITA, H
    CHIBA, H
    INTERNAL MEDICINE, 1994, 33 (07) : 432 - 436